Braemar Manufacturing, LLC recalls Monitoring Service Application (MSA). Software to process
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Not all Electrocardiogram (ECG) events received July 2022-July 2024 were not properly routed and subsequently reviewed due to an analysis step being disabled with the monitoring service application software.
- Products
-
- Monitoring Service Application (MSA). Software to process
- Company
- Braemar Manufacturing, LLC
- Where it was sold
-
US Nationwide distribution including PR.
Nationwide
- Units affected
- ~130,000 with 41,282 customers (1 software copy used)
- About this recall
- Monitoring Service Application (MSA). Software to process, analyze, display, and report cardiac events in ECG data received from compatible devices.